| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.099 | 31.866 | 43.595 | 47.282 | 49.751 | 45.294 | 47.113 | 49.606 | 52.527 | 44.751 |
| Total Income - EUR | 24.099 | 31.956 | 43.598 | 47.282 | 49.751 | 46.101 | 47.269 | 57.939 | 52.527 | 46.013 |
| Total Expenses - EUR | 33.765 | 22.029 | 41.810 | 40.644 | 34.380 | 24.656 | 29.793 | 41.575 | 57.889 | 55.564 |
| Gross Profit/Loss - EUR | -9.666 | 9.927 | 1.787 | 6.637 | 15.371 | 21.444 | 17.476 | 16.364 | -5.363 | -9.551 |
| Net Profit/Loss - EUR | -10.389 | 9.607 | 1.311 | 6.165 | 14.898 | 21.022 | 17.003 | 15.855 | -5.809 | -10.862 |
| Employees | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Ginedumimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 17.887 | 11.606 | 6.460 | 4.533 | 1.596 | 431 | 253 | 37.963 | 46.946 | 29.167 |
| Current Assets | 3.515 | 9.543 | 18.297 | 21.314 | 30.028 | 35.896 | 27.015 | 17.392 | 3.582 | 6.834 |
| Inventories | 427 | 423 | 416 | 408 | 400 | 0 | 0 | 209 | 0 | 0 |
| Receivables | 3.018 | 3.099 | 5.441 | 9.503 | 9.104 | 16.593 | 8.716 | 9.834 | 1.697 | 1.376 |
| Cash | 70 | 6.021 | 12.440 | 11.403 | 20.524 | 19.303 | 18.299 | 7.349 | 1.884 | 5.458 |
| Shareholders Funds | 10.530 | 20.031 | 14.624 | 20.521 | 28.589 | 34.493 | 26.260 | 29.176 | 16.687 | 5.731 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.559 | 1.791 | 10.778 | 6.086 | 3.976 | 2.600 | 1.177 | 26.998 | 35.034 | 31.387 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ginedumimed Srl